An exploratory PET/MR radiomics framework for preoperative prediction of HER2 status and metastatic burden in colorectal cancer
Eurasian Journal of Medicine and Oncology · 16.11.2026 · 026270322
DOI: 10.36922/ejmo026270322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 16.11.2026. Verfasst von Zengbei Yuan und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) status and metastatic burden in colorectal cancer remains challenging. Multimodal positron emission tomography (PET)/magnetic resonance (MR) radiomics offers an opportunity for integrated molecular and metastatic characterization.
Objective
To develop and internally validate an exploratory PET/MR radiomics framework for the preoperative prediction of HER2 status and metastatic burden (non-regional lymph nodes) in colorectal cancer (CRC) patients.
Methods
This retrospective study incorporated 61 samples with pathologically confirmed CRC who underwent preoperative 18F-fluorodeoxyglucose PET/MR imaging. HER2 positivity was defined according to the refined HER2 Amplification for CRC Enhanced Stratification criteria. Metastatic burden was categorized into three groups based on preoperative imaging: non-metastatic, regional lymph node metastasis, and distant metastasis. Tumor regions were manually segmented on PET, T1- and T2-weighted imaging (T1WI, T2WI), and 2,264 radiomic features were extracted from each imaging modality. Feature selection was performed using a comprehensive multi-step pipeline. An extreme gradient boosting (XGBoost)-based model was then developed and internally validated via 5-fold cross-validation, with performance metrics reported as mean ± standard deviation.
Results
For HER2 status prediction, the multimodal combined XGBoost model demonstrated superior performance compared to single-modality models, yielding a mean AUC of 0.9214 ± 0.0779. For metastatic burden prediction, the combined model further excelled, yielding an AUC of 0.827 ± 0.136. SHapley Additive exPlanations analysis revealed imaging signatures for the two prediction tasks. HER2 status prediction was primarily driven by texture-related features, particularly those derived from the Gray-Level Run Length Matrix, Gray-Level Co-occurrence Matrix, and First-order matrices, whereas metastatic burden prediction relied mainly on multiscale texture descriptors from the first-order, Neighborhood Gray-Tone Difference Matrix, and Gray-Level Dependence Matrix.
Conclusion
PET/MR radiomics offers an exploratory approach for future risk stratification in CRC, although independent validation is required to confirm clinical utility.
Zitieren
APA
Yuan, Z., Wang, K., Jiang, W., Tang, Z., Chen, X., Wang, W., Yang, Y., Zhou, Z., Zhao, J., Huang, Q., & Qi, N. (2026). An exploratory PET/MR radiomics framework for preoperative prediction of HER2 status and metastatic burden in colorectal cancer. Eurasian Journal of Medicine and Oncology, 0(0), 026270322. https://doi.org/10.36922/ejmo026270322
Vancouver
Yuan Z, Wang K, Jiang W, Tang Z, Chen X, Wang W, et al. An exploratory PET/MR radiomics framework for preoperative prediction of HER2 status and metastatic burden in colorectal cancer. Eurasian Journal of Medicine and Oncology. 2026;0(0):026270322. doi:10.36922/ejmo026270322
BibTeX
@article{Yuan2026,
author = {Yuan, Zengbei and Wang, Kun and Jiang, Wen and Tang, Zhixian and Chen, Xing and Wang, Weilun and Yang, Yihong and Zhou, Zirong and Zhao, Jun and Huang, Qingqing and Qi, Na},
title = {An exploratory PET/MR radiomics framework for preoperative prediction of HER2 status and metastatic burden in colorectal cancer},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {0},
number = {0},
pages = {026270322},
doi = {10.36922/ejmo026270322}
}
EUVIMED